Fennec Pharmaceuticals Inc. Common Stock

AED36.62
AED
Last updated on --.
24h volume219.62K
24h highest37.2269 AED
24h lowest35.6261 AED
24h Price movement+0.81%

FENC recent prices

24 Hours
+0.81%+AED0.29385
30 days
+49.87%+AED12.27
60 days
+74.02%+AED15.68
90 days
+18.27%+AED5.696

Key data

Previous close36.3270 AED
Market cap1.24B AED
Volume219.62K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.88154 AED
Net income (FY)-30.77M AED
Revenue (FY)187.32M AED
Last report date14 May 2026

About Fennec Pharmaceuticals Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersRESEARCH TRIANGLE PARK
Employees (FY)35.00
Revenue per employee (FY)5.35M AED
Net income per employee (FY)-879.03K AED
Listed onNasdaq
Official website

FENC conversion tables

FENCFENC
AEDAED
0.5 FENC18.31 AED
1 FENC36.62 AED
5 FENC183.1 AED
10 FENC366.2 AED
AEDAED
FENCFENC
0.5 AED0.013653 FENC
1 AED0.027307 FENC
5 AED0.13653 FENC
10 AED0.27307 FENC

FAQ

FENC is trading at AED36.62, +0.81% over the last 24 hours. Track live moves on the price chart at the top of this page.
The FENC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. FENC is currently trading at AED36.62, +0.81% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on FENC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. FENC's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from FENC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against FENC's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Fennec Pharmaceuticals Inc. Common Stock's market cap is currently 1.24B AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume219.62K
24h highest37.2269 AED
24h lowest35.6261 AED
24h Price movement+0.81%
FENCFENC
AEDAED
Start trade with FENC Perpetual